Fresenius SE & Co. KGaA Stock

Equities

FRE

DE0005785604

Healthcare Facilities & Services

Market Closed - Xetra 11:35:28 2024-05-09 EDT 5-day change 1st Jan Change
28.03 EUR -1.58% Intraday chart for Fresenius SE & Co. KGaA +0.21% -0.14%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Days!
Take advantage of the offer
* See conditions on site

Financials

Sales 2024 * 22.98B 24.78B 33.88B Sales 2025 * 24.08B 25.96B 35.5B Capitalization 15.79B 17.03B 23.28B
Net income 2024 * 1.45B 1.56B 2.14B Net income 2025 * 1.78B 1.92B 2.63B EV / Sales 2024 * 1.3 x
Net Debt 2024 * 14.11B 15.22B 20.81B Net Debt 2025 * 13.36B 14.41B 19.7B EV / Sales 2025 * 1.21 x
P/E ratio 2024 *
10.7 x
P/E ratio 2025 *
8.8 x
Employees 193,865
Yield 2024 *
3.32%
Yield 2025 *
3.77%
Free-Float 73.04%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.58%
1 week+0.21%
Current month+0.21%
1 month+9.36%
3 months+10.57%
6 months+8.94%
Current year-0.14%
More quotes
1 week
27.42
Extreme 27.42
29.55
1 month
25.09
Extreme 25.09
29.55
Current year
24.32
Extreme 24.32
29.55
1 year
23.93
Extreme 23.93
31.22
3 years
19.69
Extreme 19.69
47.60
5 years
19.69
Extreme 19.69
51.85
10 years
19.69
Extreme 19.69
80.07
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 21-04-11
Director of Finance/CFO 44 18-12-31
Compliance Officer - 23-07-17
Members of the board TitleAgeSince
Director/Board Member 69 15-05-19
Director/Board Member 63 16-05-12
Director/Board Member 64 07-07-15
More insiders
Date Price Change Volume
24-05-09 28.03 -1.58% 1,017,940
24-05-08 28.48 +1.24% 2,123,832
24-05-07 28.13 +0.93% 1,560,800
24-05-06 27.87 -0.29% 778,869
24-05-03 27.95 -0.07% 879,482

Delayed Quote Xetra, May 09, 2024 at 11:35 am

More quotes
Fresenius SE & Co. KGaA specializes in designing, producing, and selling medical drugs, equipment, and devices used in clinical hospitalization and at home. Net sales break down by activity as follows: - dialysis treatment (46.9%; Fresenius Medical Care): sales of equipment for hemodialysis, pediatric dialysis, peritoneal dialysis, dialysis services, etc.; - hospital administration and engineering (34.1%; Fresenius Vamed and Fresenius Helios): management of technical facilities and medical equipment, hospital management, design and production of medical equipment for the pharmaceutical sector, etc.; - perfusion and clinical nutrition (19%; Fresenius Kabi): sales of parenteral and oral nutrition products, perfusion and vascular filling equipment, transfusion materials, generic injectable products, home medical assistance services in the areas of perfusion, nutrition, and oxygen therapy, etc. Net sales are distributed geographically as follows: Europe (43.8%), North America (39.4%), Asia/Pacific (10.1%), Latin America (5.4%) and Africa (1.3%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
28.03 EUR
Average target price
36.28 EUR
Spread / Average Target
+29.44%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW